InvestSMART

Genetic Signatures Limited (ASX:GSS)

ALERT: Price-sensitive ASX Announcement for GSS
Current share price for GSS : $0.087 0.021 (31.82%)+
Announcement
Release
2 Jul 2026 2:41PM
Price at Release
$0.066
Full Release
download
Summary
Genetic Signatures Limited, in response to BCAL Diagnostics' announcement about acquiring shares in the company, stated it was not notified in advance and had no prior knowledge of the proposed acquisition. As of the announcement, no substantial holder notice has been received or lodged with the ASX. The company reassures its stakeholders that it continues to operate as usual and remains focused on its strategic and operational objectives, while committing to keep the market informed of any developments according to disclosure obligations.
Key Points
  • Genetic Signatures Limited was not notified in advance about BCAL Diagnostics' announcement regarding share acquisition.
  • No substantial holder notice has been received or lodged with the ASX regarding the share acquisition.
  • Genetic Signatures remains focused on executing its strategic plan and operational objectives.
  • The company reassures stakeholders of its commitment to business continuity and value creation.
  • Genetic Signatures will keep the market informed of any material developments as per continuous disclosure obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.